Theseus Pharmaceuticals

-$0.37 (-4.91%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell THRX and other ETFs, options, and stocks.

About THRX

Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies.

CEO
Timothy P. Clackson
Employees
—
Headquarters
Cambridge, Massachusetts
Founded
2017

THRX Key Statistics

Market cap
277.50M
Price-Earnings ratio
—
Dividend yield
—
Average volume
81.77K
High today
$7.87
Low today
$7.10
Open price
$7.60
Volume
71.95K
52 Week high
$24.54
52 Week low
$6.73

THRX Earnings

-$5.16
-$3.51
-$1.87
-$0.22
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.26 per share
Actual
-$0.27 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure